Canada - Toronto Stock Exchange - TSX:TSND - CA88105E1088 - Common Stock
The current stock price of TSND.CA is 0.79 CAD. In the past month the price decreased by -18.56%. In the past year, price decreased by -26.17%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.85 | 3.66B | ||
| CRON.CA | CRONOS GROUP INC | 23.33 | 1.34B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.24B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.38 | 914.83M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.14 | 637.07M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 601.70M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 582.17M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 426.65M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.14 | 376.74M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 361.18M | ||
| HITI.CA | HIGH TIDE INC | N/A | 320.17M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 296.87M |
TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.
TERRASCEND CORP
3610 Mavis Road
Mississauga ONTARIO CA
Employees: 1057
Phone: 18558377295
TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2017-05-03. The firm has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The firm operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. The company has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The firm owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. The company also operates a cannabis dispensary located in Goshen Township, Ohio.
The current stock price of TSND.CA is 0.79 CAD. The price increased by 19.7% in the last trading session.
TSND.CA does not pay a dividend.
TSND.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
TSND.CA stock is listed on the Toronto Stock Exchange exchange.
TERRASCEND CORP (TSND.CA) has a market capitalization of 292.09M CAD. This makes TSND.CA a Micro Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA. TSND.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months TSND.CA reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS decreased by -25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.71% | ||
| ROE | -128.44% | ||
| Debt/Equity | 2.26 |
9 analysts have analysed TSND.CA and the average price target is 1.79 CAD. This implies a price increase of 125.95% is expected in the next year compared to the current price of 0.79.
For the next year, analysts expect an EPS growth of 55.61% and a revenue growth -13.46% for TSND.CA